NCT02665871

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
• Sex: All
• Age: 3 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the safety of freeze-dried live attenuated influenza vaccine for intranasal administration in chinese adults aged 3 years and older.80 subjects will be divided into 2 groups, including 18 years and older and 3-17 years old. Subjects in each groups will randomly receive one dose of influenza vaccine or placebo in a 3:1 ratio.

Conditions

• Influenza

Interventions

Type	Name	Description
BIOLOGICAL	one dose of Influenza Vaccine
BIOLOGICAL	one dose of Influenza Vaccine
BIOLOGICAL	placebo
BIOLOGICAL	placebo

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-06-01
• Completion: 2016-09-01
• First posted: 2016-01-28
• Last updated: 2016-08-15